Zobrazeno 1 - 10
of 119
pro vyhledávání: '"therapeutic alternatives"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Rosa María Damas Fuentes, Moisés Pérez León, Marta Piñero González, Nayra Sangil Monroy, Rafael Molero Gómez, Pablo Domínguez Lantigua
Publikováno v:
Farmacia Hospitalaria, Vol 39, Iss 1, Pp 44-58 (2015)
Objetive: To analyze the latex content of drugs in hospital formulary and establish possible therapeutic alternatives. Methods: All drugs susceptible of having latex were selected and written information was obtained from manufacturers. A therapeutic
Externí odkaz:
https://doaj.org/article/bb0eab36450e41ef83ddb44de3db4409
Autor:
Damon C. Scales, David Williamson, Salmaan Kanji, Lisa Burry, Jin-Hyeun Huh, David Neilipovitz, Deep Patel, Michelle Pittman, Robert MacLean, Sabrina Natarajan, Samuel Dubinsky
Publikováno v:
Canadian Journal of Anaesthesia
Canadian Journal of Anesthesia/Journal canadien danesthésie
Canadian Journal of Anesthesia/Journal canadien danesthésie
During the coronavirus disease (COVID-19) global pandemic, urgent strategies to alleviate shortages are required. Evaluation of the feasibility, practicality, and value of drug conservation strategies and therapeutic alternatives requires a collabora
Autor:
Lazarin-Bidóia, Danielle, Garcia, Francielle Pelegrin, Ueda-Nakamura, Tânia, Silva, Sueli de Oliveira, Nakamura, Celso Vataru
Publikováno v:
Memórias do Instituto Oswaldo Cruz, Volume: 117, Article number: e220396, Published: 30 MAR 2022
Over the past years, natural products have been explored in order to find biological active substances to treat various diseases. Regarding their potential action against parasites such as trypanosomatids, specially Trypanosoma cruzi and Leishmania s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______608::ca3b2b088ae5b49e07bab2d430d0a4ca
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762022000100861&lng=en&tlng=en
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762022000100861&lng=en&tlng=en
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Recent Patents on Anti-Infective Drug Discovery. 13:190-197
Background Heavily treated HIV-1 infected patients may have limited therapeutic alternatives. In order to ensure sustained HIV-RNA suppression in these patients and to improve current antiretroviral treatment regimens in the fight against multi-drug
Publikováno v:
Pharmaceuticals
Pharmaceuticals, 2021, 14 (5), pp.488. ⟨10.3390/ph14050488⟩
Pharmaceuticals, Vol 14, Iss 488, p 488 (2021)
Pharmaceuticals, MDPI, 2021, 14 (5), pp.488. ⟨10.3390/ph14050488⟩
Pharmaceuticals, 2021, 14 (5), pp.488. ⟨10.3390/ph14050488⟩
Pharmaceuticals, Vol 14, Iss 488, p 488 (2021)
Pharmaceuticals, MDPI, 2021, 14 (5), pp.488. ⟨10.3390/ph14050488⟩
International audience; Immunodepression, whether due to HIV infection or organ transplantation, has increased human vulnerability to fungal infections. These conditions have created an optimal environment for the emergence of opportunistic infection
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::76d2f939cfedaa0302e5fcf892e8806a
https://hal-amu.archives-ouvertes.fr/hal-03308207/document
https://hal-amu.archives-ouvertes.fr/hal-03308207/document
Autor:
Acosta Mora, Carmen Rosa
Publikováno v:
Repositorio Universidad Javeriana
Pontificia Universidad Javeriana
instacron:Pontificia Universidad Javeriana
Pontificia Universidad Javeriana
instacron:Pontificia Universidad Javeriana
Helicobacter pylori es una bacteria que presenta tropismo por las células del epitelio gástrico, se estima que el 60% de la población mundial está infectada por este microorganismo y Colombia presenta una prevalencia entre 70-78%. En el 100% de l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3056::143138fd3ee742f0503b4ba7147ac133
Autor:
Carlos J. Alméciga-Díaz, Diego Suárez, Olga Yaneth Echeverri-Peña, Andres Felipe Leal, Daniela Solano-Galarza, Eliana Benincore-Flórez, Angela J. Espejo-Mojica, Rafael Guillermo Garzón Jaramillo
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 6213, p 6213 (2020)
International Journal of Molecular Sciences
International Journal of Molecular Sciences
GM2 gangliosidoses are a group of pathologies characterized by GM2 ganglioside accumulation into the lysosome due to mutations on the genes encoding for the β-hexosaminidases subunits or the GM2 activator protein. Three GM2 gangliosidoses have been